Famotidine Powder, For Suspension
Product Images NDC 0527-5190

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 0527-5190). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Famotidine For Oral Suspension Usp 1)

FDA Label Image

Bottle Label (Famotidine For Oral Suspension Usp 2)

Bottle Label (Famotidine For Oral Suspension Usp 2)
This text provides instructions for the constitution, storage, and dispensing of Famotidine oral suspension. It includes details on recommended dosage, directions for constitution, storage temperature, and shelf life after reconstitution. The suspension should be protected from freezing and discarded after 30 days. The pharmacist must reconstitute it before dispensing. The text also mentions the concentration of famotidine in the suspension and the NDC code for identification.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.